Cytokinetics | CYTK - Trade Creditors

Stock Price
75.85
Daily Change
-2.79 -3.55%
Monthly
15.94%
Yearly
144.68%
Q2 Forecast
74.33

Cytokinetics reported $24.71M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Arca Biopharma USD 4.16M 1.95M Dec/2025
Bayer EUR 6.59B 496M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Brainstorm Cell Therapeutics USD 7.32M 250K Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Capricor Therapeutics 3.93M 2.27M Mar/2026
Cytokinetics USD 24.71M 80.91M Mar/2026
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Exelixis USD 24.15M 5.47M Mar/2026
Geron USD 12.72M 1.46M Mar/2026
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026